Augustine Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Sell
34,042
-751
-2% -$32.3K 0.33% 39
2026
Q1
$1.28M Buy
34,793
+945
+3% +$44.8K 0.29% 47
2025
Q4
$1.72M Sell
33,848
-784
-2% -$40.1K 0.34% 39
2025
Q3
$1.92M Buy
34,632
+14,790
+75% +$866K 0.39% 38
2025
Q2
$1.37M Buy
19,842
+104
+0.5% +$7.07K 0.37% 44
2025
Q1
$1.37M Buy
19,738
+54
+0.3% +$4.46K 0.4% 42
2024
Q4
$1.69M Buy
+19,684
New +$2.13M 0.45% 37
2016
Q4
Sell
-96,150
Closed -$2M 68
2016
Q3
$2M Sell
96,150
-270
-0.3% -$6.69K 1.47% 24
2016
Q2
$2.59M Buy
+96,420
New +$2.64M 2.07% 18
2016
Q1
Sell
-137,376
Closed -$3.99M 57
2015
Q4
$3.99M Buy
137,376
+2,076
+2% +$57.5K 3.08% 13
2015
Q3
$3.67M Buy
135,300
+120
+0.1% +$3.4K 2.8% 14
2015
Q2
$3.7M Buy
135,180
+60
+0% +$1.69K 2.76% 14
2015
Q1
$3.82M Buy
+135,120
New +$3.11M 2.69% 13

Other funds holding NVO

Augustine Asset Management's NVO Position: Q2 2026 in Review

Augustine Asset Management reduced its Novo Nordisk (NVO) stake by 2.2% in Q2 2026, selling an estimated $32.3K and leaving 34,042 shares worth $1.63M. The position accounts for 0.33% of the portfolio, ranked #39.

Augustine Asset Management first reported a position in NVO in Q1 2015 and has held it in 13 quarters since. The position peaked at $3.99M in Q4 2015. 205 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Augustine Asset Management held 34,042 shares of Novo Nordisk worth $1.63M as of Q2 2026.
  • Augustine Asset Management sold 751 Novo Nordisk shares in Q2 2026, an estimated $32.3K.
  • Novo Nordisk made up 0.33% of Augustine Asset Management's portfolio in Q2 2026, its #39 holding.
  • Augustine Asset Management first reported a position in Novo Nordisk in Q1 2015 and has held it in 13 quarters since.
  • Augustine Asset Management's Novo Nordisk position peaked at $3.99M in Q4 2015.
  • 205 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Augustine Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.